Doseology Sciences, Inc. (TSE:MOOD)

:MOOD

MOOD

Doseology Sciences

RESEARCH TOOLSreports

Doseology Sciences (MOOD) Price & Analysis

6 Followers

MOOD Stock Chart & Stats

C$0.53

C$0.00(0.00%)

At close: Dec 31 4:00 PM EST

C$0.53

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.15 - C$1.90

Previous CloseN/A

Volume0.00

Average Volume (3M)1.79K

Market Cap

C$4.41M

Enterprise ValueC$1.81M

Total Cash (Recent Filing)C$1.43M

Total Debt (Recent Filing)C$0.00

Price to Earnings (P/E)―

Beta-3.38

Next Earnings

Jun 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.04

Shares Outstanding8,011,621

10 Day Avg. Volume3,383

30 Day Avg. Volume1,793

Financial Highlights & Ratios

PEG Ratio-0.49

Price to Book (P/B)3.46

Price to Sales (P/S)113.73

P/FCF Ratio-14.14

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthVirtually no debt and equity that exceeds assets give the company durable financial flexibility. Over a 2–6 month horizon this reduces leverage risk and interest service burden, supporting continued R&D and product development without immediate refinancing pressure.

Improving Cash Burn TrendMaterial improvement in cash burn versus prior years lengthens the company's operational runway and reduces near-term financing pressure. If sustained, this trend lowers funding frequency and supports more strategic allocation to commercialization and product development.

Positive Gross Profit / Product EconomicsConsistent positive gross profit indicates underlying unit economics for products are viable. With disciplined operating-cost control and scale, positive gross margins can translate into sustainable profits as revenues grow and fixed costs are absorbed over time.

Bears Say

Persistent Operating LossesSustained operating losses and negative free cash flow erode shareholder equity and constrain the company's ability to self-fund growth. Over months this makes strategic investments harder and increases reliance on external financing or cost-cutting to reach profitability.

Revenue Volatility And Recent DeclineA small, volatile and recently declining revenue base limits scalability and predictability of cash flows. This structural fragility hampers the company's ability to cover fixed operating costs, plan longer-term product launches, or demonstrate repeatable commercial traction.

Dependence On External CapitalOngoing negative operating cash flow means the company will likely need external funding to sustain operations or invest. This creates dilution and execution risk over time and makes strategy contingent on access to capital markets or partners rather than organic cash generation.

Doseology Sciences News

Doseology launches $2 million private placement to fund oral stimulant pouch rollout

Doseology Sciences ( ($TSE:MOOD) ) has issued an announcement. Doseology Sciences Inc. has arranged a non-brokered private placement...

7d ago

Doseology Uplists to OTCQB to Advance Growth in Oral Stimulant Pouch Market

An announcement from Doseology Sciences ( ($TSE:MOOD) ) is now available. Doseology Sciences Inc. has uplisted its common...

26d ago

Doseology debuts nicotine-free energy pouches in U.S. direct-to-consumer pilot

Doseology Sciences ( ($TSE:MOOD) ) has shared an announcement. Doseology Sciences has launched its Feed That Brain Energy...

1M ago

Doseology Taps Veteran Pharmacy Executive Larry Latowsky as Executive Chairman to Steer Commercial Expansion

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an update. Doseology Sciences has appointed veteran retail and healthcare executive...

2M ago

Doseology Launches Pilot for Caffeine Energy Pouches Under Feed That Brain Brand

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an update. Doseology Sciences has begun a pilot production run of...

3M ago

Doseology Boosts Transparency With New Annual Information Form Filing

Doseology Sciences ( ($TSE:MOOD) ) has issued an update. Doseology Sciences Inc. has filed its Annual Information Form...

3M ago

Doseology Taps McKinney Advisors to Fast-Track Regulatory Path for Oral Pouch Line

Doseology Sciences ( ($TSE:MOOD) ) just unveiled an announcement. Doseology Sciences has entered a strategic partnership with McKinney...

3M ago

Doseology Launches Investor Communications Initiative to Boost Market Engagement

The latest update is out from Doseology Sciences ( ($TSE:MOOD) ). Doseology Sciences Inc. has launched an Investor...

4M ago

Doseology Secures Strategic Manufacturing Agreement for Market Readiness

Doseology Sciences ( ($TSE:MOOD) ) has issued an announcement. Doseology Sciences Inc. has announced a significant milestone with...

5M ago

Doseology Sciences Expands Portfolio with Strategic Acquisition

An update from Doseology Sciences ( ($TSE:MOOD) ) is now available. Doseology Sciences Inc. has completed the acquisition...

7M ago

MOOD FAQ

What was Doseology Sciences, Inc.’s price range in the past 12 months?

Doseology Sciences, Inc. lowest stock price was C$0.15 and its highest was C$1.90 in the past 12 months.

What is Doseology Sciences, Inc.’s market cap?

Doseology Sciences, Inc.’s market cap is C$4.41M.

When is Doseology Sciences, Inc.’s upcoming earnings report date?

Doseology Sciences, Inc.’s upcoming earnings report date is Jun 01, 2026 which is in 55 days.

How were Doseology Sciences, Inc.’s earnings last quarter?

Doseology Sciences, Inc. released its earnings results on Mar 01, 2022. The company reported -C$0.139 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.139.

Is Doseology Sciences, Inc. overvalued?

According to Wall Street analysts Doseology Sciences, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Doseology Sciences, Inc. pay dividends?

Doseology Sciences, Inc. does not currently pay dividends.

What is Doseology Sciences, Inc.’s EPS estimate?

Doseology Sciences, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Doseology Sciences, Inc. have?

Doseology Sciences, Inc. has 8,011,621 shares outstanding.

What happened to Doseology Sciences, Inc.’s price movement after its last earnings report?

Doseology Sciences, Inc. reported an EPS of -C$0.139 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Doseology Sciences, Inc.?

Currently, no hedge funds are holding shares in TSE:MOOD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Doseology Sciences, Inc.

Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada. It focuses on research, development, and sale of medicinal mushroom products, including tinctures and powders. The company sells its products online through doseology.com. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.